US SB2141 | 2013-2014 | 113th Congress
Status
Completed Legislative Action
Spectrum: Bipartisan Bill
Status: Passed on November 26 2014 - 100% progression
Action: 2014-11-26 - Became Public Law No: 113-195.
Text: Latest bill text (Enrolled) [PDF]
Spectrum: Bipartisan Bill
Status: Passed on November 26 2014 - 100% progression
Action: 2014-11-26 - Became Public Law No: 113-195.
Text: Latest bill text (Enrolled) [PDF]
Summary
Sunscreen Innovation Act - (Sec. 2) Amends the Federal Food, Drug, and Cosmetic Act to establish a process for the review and approval of over-the-counter (OTC) sunscreen active ingredients. Allows any person to request that the Secretary of Health and Human Services (HHS) determine whether an OTC sunscreen active ingredient or combination of ingredients is safe and effective. Requires the Secretary to review any request regarding a sunscreen active ingredient or combination of ingredients that has been in use and that is not included in the stayed sunscreen monograph published by the Food and Drug Administration (FDA). Directs the Secretary to invite the sponsor of the request to provide data and other information on the safety and efficacy of the sunscreen active ingredient or combination of ingredients. Requires the Secretary to determine whether the provided information is sufficient to conduct a review, and if so, file the request, and if not, explain to the sponsor why the provided information is insufficient. Requires the Director of the Center for Drug Evaluation and Research to complete a review of a filed request and determine the safety and efficacy of the sunscreen active ingredient or combination of ingredients within 300 days for new requests or a shorter timeframe for requests pending before enactment of this Act. Directs the Commissioner of Food and Drugs to make the determination if the Director does not make a determination in the allowed timeframe. Allows sunscreen active ingredients that are determined to be safe and effective to be used in OTC sunscreen products. Allows the Secretary to amend a determination if additional information becomes available. (Sec. 3) Allows sponsors of eligible non-sunscreen OTC drug applications to request that the Secretary provide a framework for review of their application. Requires the Secretary to respond with framework options, including options that follow the review process set forth in this Act for sunscreen active ingredients. (Sec. 4) Directs the Comptroller General (GAO) to report on the progress of the Secretary in establishing this process and the role of the Commissioner of Food and Drugs in issuing determinations on pending requests. Requires the Secretary to report on the decisions made about the safety and efficacy of sunscreen active ingredients, the amount of time between submission and decision for each request, the cost of the review process, and recommended improvements to the review process.
Title
Sunscreen Innovation Act
Sponsors
Sen. Jack Reed [D-RI] | Sen. Lamar Alexander [R-TN] | Sen. Kelly Ayotte [R-NH] | Sen. Cory Booker [D-NJ] |
Sen. Sherrod Brown [D-OH] | Sen. Richard Burr [R-NC] | Sen. Thomas Carper [D-DE] | Sen. Christopher Coons [D-DE] |
Sen. Kay Hagan [D-NC] | Sen. Tom Harkin [D-IA] | Sen. Johnny Isakson [R-GA] | Sen. Mark Kirk [R-IL] |
Sen. Mary Landrieu [D-LA] | Sen. Mitch McConnell [R-KY] | Sen. Rand Paul [R-KY] | Sen. Rob Portman [R-OH] |
Sen. Pat Roberts [R-KS] | Sen. Charles Schumer [D-NY] | Sen. Tim Scott [R-SC] | Sen. Elizabeth Warren [D-MA] |
History
Date | Chamber | Action |
---|---|---|
2014-11-26 | House | Became Public Law No: 113-195. |
2014-11-26 | House | Signed by President. |
2014-11-19 | House | Presented to President. |
2014-11-13 | House | Motion to reconsider laid on the table Agreed to without objection. |
2014-11-13 | House | On passage Passed without objection. (text: CR H7959-7964) |
2014-11-13 | House | Considered by unanimous consent. (consideration: CR H7959-7964) |
2014-11-13 | House | Mr. Latta asked unanimous consent to take from the Speaker's table and consider. |
2014-09-18 | House | Held at the desk. |
2014-09-18 | House | Received in the House. |
2014-09-18 | Senate | Message on Senate action sent to the House. |
2014-09-17 | Senate | Passed Senate with an amendment by Unanimous Consent. (consideration: CR S5715-5720; text as passed Senate: CR S5715-5720) |
2014-09-17 | Senate | Placed on Senate Legislative Calendar under General Orders. Calendar No. 568. |
2014-09-17 | Senate | Committee on Health, Education, Labor, and Pensions. Reported by Senator Harkin with an amendment in the nature of a substitute. Without written report. |
2014-09-17 | Senate | Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably. |
2014-03-13 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB4250 (Same As) 2014-07-29 - Received in the Senate.
Subjects
Congressional oversight
Consumer affairs
Drug safety, medical device, and laboratory regulation
Health
Health promotion and preventive care
Musculoskeletal and skin diseases
Consumer affairs
Drug safety, medical device, and laboratory regulation
Health
Health promotion and preventive care
Musculoskeletal and skin diseases